Table 1 Evaluation & testing; COVID-19 symptoms screening criteria

US

> 100.4 °F / 38 °C

Cough, difficulty breathing

N/A

N/A

N/A

N/A

N/A

With symptoms

With underlying conditions

China

Fever

Any respiratory symptoms

Multiple patchy shadows and interstitial changes at the lungs

CT imaging features of COVID-19 / either WBC or lymphocyte count decreases

Within 14 days before the onset of the disease

Within 14 days before the onset of the disease

Within 14 days before the onset of the disease

N/A

N/A

South Korea

≥37.5 °C

Coughing, difficulty breathing

Unknow case of pneumonia

N/A

Within 14 days with respiratory symptoms

Within 14 days with respiratory symptoms

Within 14 days with respiratory symptoms

N/A

N/A

UK (Only for inpatients)

≥37.8 °C

Persistent cough (with or without sputum), hoarseness, nasal discharge or congestion, shortness of breath, sore throat, wheezing, sneezing

Clinical or radiological evidence of pneumonia

Acute respiratory distress syndrome or influenza

N/A

N/A

N/A

N/A

N/A

Brazil

N/A

Coughing, runny nose, difficulty breathing

N/A

N/A

***

Possible patients

Travel abroad in the last 14 days

N/A

N/A

Haiti

≥38 °C

Cough with or without respiratory difficulties, headache, body aches, sudden changes in taste and smell

Acute upper respiratory infection with a tendency to develop pneumonia or broncho-pneumonia

N/A

Possibly having had contact with a confirmed COVID-19

Contact with a sick person

Within 14 days with flu symptoms

N/A

N/A